<DOC>
	<DOCNO>NCT01262456</DOCNO>
	<brief_summary>The purpose trial confirm/establish long-term safety efficacy desmopressin orally disintegrate tablet dose level 50 μg 75 μg evaluate safety efficacious high dose level 100 μg male nocturia .</brief_summary>
	<brief_title>Investigation Superiority Effect Orally Disintegrating Desmopressin Tablets Placebo Terms Night Voids Reduction Nocturia Adult Male Patients</brief_title>
	<detailed_description />
	<mesh_term>Nocturia</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<criteria>Written inform consent prior performance trialrelated activity Male sex 18 year age old At least 2 void every night consecutive 3day period screen period base patient diary . Evidence severe daytime void dysfunction define : Urge urinary incontinence ( 1 episode/day 3day diary period ) , Urgency ( 1 episode/day 3day diary period ) , Frequency ( 8 daytime voids/day 3day diary period ) Interstitial Cystitis Chronic prostatitis/chronic pelvic pain syndrome Suspicion bladder outlet obstruction ( BOO ) urine flow less 5 mL/s confirm uroflowmetry perform suspicion BOO Surgical treatment , include transurethral resection , BOO benign prostatic hyperplasia within past 6 month Urinary retention post void residual volume excess 250 mL confirm bladder ultrasound perform suspicion urinary retention Habitual psychogenic fluid intake result urine production exceed 40 mL/kg/24 hour Central nephrogenic diabetes insipidus . Syndrome inappropriate antidiuretic hormone . Current history urologic malignancy e.g . urothelium , prostate , kidney cancer Genitourinary tract pathology e.g . infection stone bladder urethra cause symptom Neurogenic detrusor activity ( detrusor overactivity ) Suspicion evidence cardiac failure Uncontrolled hypertension Uncontrolled diabetes mellitus Hyponatraemia : Serum sodium level must within normal limit Renal insufficiency : Serum creatinine must within normal limit estimate glomerular filtration rate must equal 50 mL/min Hepatic and/or biliary disease : Aspartate aminotransferase ( AST ) and/or alanine aminotransferase ( ALT ) level must twice upper limit normal range . Total bilirubin level must 1.5 mg/dL History obstructive sleep apnea Previous desmopressin treatment nocturia Treatment another investigational product within 3 month prior screen Concomitant treatment prohibit medication , i.e . loop diuretic ( furosemide , torsemide , ethacrynic acid ) investigational drug Known alcohol substance abuse Work lifestyle may interfere regular nighttime sleep e.g . shift worker Any medical condition , laboratory abnormality , psychiatric condition , mental incapacity , language barrier , judgment investigator , would impair participation trial</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>